Author Archives: Scalper1

Valeant Q3 Seen Strong, But Political Concerns Weigh

Specialty-drug giant Valeant Pharmaceuticals (VRX) is set to report Q3 earnings Monday before the open, but the company’s emerging role as chief villain to drug-price critics is already overshadowing the report. On Wednesday, Valeant said that it had received subpoenas from district attorneys in Massachusetts and New York after members of both the House and Senate advocated looking into the enormous price increases that the company has given some

AT&T-DirecTV Better Than Verizon Wireless: Nomura

AT&T’s (T) bold move to acquire satellite-TV leader DirecTV Group gives it synergies other wireless firms lack, while T-Mobile US’s market share gains will likely continue, Nomura Securities said in initiating coverage on both stocks with a buy rating. But Jeffrey Kvaal, an analyst at Nomura, dished out neutral ratings on Verizon Communications (VZ) and Sprint (S) in his initiation note. AT&T stock was up 1% in morning trading in the stock market